These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 9303362)

  • 1. Semiquantification of circulating hepatocellular carcinoma cells by reverse transcriptase polymerase chain reaction.
    Wong IH; Leung T; Ho S; Lau WY; Chan M; Johnson PJ
    Br J Cancer; 1997; 76(5):628-33. PubMed ID: 9303362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative comparison of alpha-fetoprotein and albumin mRNA levels in hepatocellular carcinoma/adenoma, non-tumor liver and blood: implications in cancer detection and monitoring.
    Wong IH; Lau WY; Leung T; Johnson PJ
    Cancer Lett; 2000 Aug; 156(2):141-9. PubMed ID: 10880763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating tumor cell mRNAs in peripheral blood from hepatocellular carcinoma patients under radiotherapy, surgical resection or chemotherapy: a quantitative evaluation.
    Wong IH; Yeo W; Leung T; Lau WY; Johnson PJ
    Cancer Lett; 2001 Jun; 167(2):183-91. PubMed ID: 11369140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematogenous dissemination of hepatocytes and tumor cells after surgical resection of hepatocellular carcinoma: a quantitative analysis.
    Wong IH; Lau WY; Leung T; Yeo W; Johnson PJ
    Clin Cancer Res; 1999 Dec; 5(12):4021-7. PubMed ID: 10632334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of alpha-fetoprotein mRNA, an indicator of hematogenous spreading hepatocellular carcinoma, in the circulation: a possible predictor of metastatic hepatocellular carcinoma.
    Matsumura M; Niwa Y; Kato N; Komatsu Y; Shiina S; Kawabe T; Kawase T; Toyoshima H; Ihori M; Shiratori Y
    Hepatology; 1994 Dec; 20(6):1418-25. PubMed ID: 7527002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correlation between serum alpha-fetoprotein variant levels in patients with hepatocellular carcinoma and the presence of alpha-fetoprotein mRNA in the circulating blood].
    Kang XY; Yin ZF; Qian HH; Wu ZD; Yu ZX; Wu MC
    Zhonghua Gan Zang Bing Za Zhi; 2003 Jan; 11(1):17-9. PubMed ID: 12546734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between recurrence of hepatocellular carcinoma and alpha-fetoprotein messenger RNA levels in peripheral blood.
    Morimoto O; Nagano H; Miyamoto A; Fujiwara Y; Kondo M; Yamamoto T; Ota H; Nakamura M; Wada H; Damdinsuren B; Marubashi S; Dono K; Umeshita K; Nakamori S; Sakon M; Monden M
    Surg Today; 2005; 35(12):1033-41. PubMed ID: 16341483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitive assay for detection of hepatocellular carcinoma associated gene transcription (alpha-fetoprotein mRNA) in blood.
    Matsumura M; Niwa Y; Hikiba Y; Okano K; Kato N; Shiina S; Shiratori Y; Omata M
    Biochem Biophys Res Commun; 1995 Feb; 207(2):813-8. PubMed ID: 7532405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The detection of circulating hepatocellular carcinoma cells in peripheral venous blood by reverse transcription-polymerase chain reaction and its clinical significance].
    Liu Y; Zhang B; Qian G; Chen H; Wu M; Fu J; Huang C
    Zhonghua Wai Ke Za Zhi; 1998 Oct; 36(10):608-10. PubMed ID: 11825477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective evaluation of circulating hepatocytes by alpha-fetoprotein mRNA in humans during liver surgery.
    Lemoine A; Le Bricon T; Salvucci M; Azoulay D; Pham P; Raccuia J; Bismuth H; Debuire B
    Ann Surg; 1997 Jul; 226(1):43-50. PubMed ID: 9242336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human telomerase reverse transcriptase messenger RNA (TERT mRNA) as a tumour marker for early detection of hepatocellular carcinoma.
    El-Mazny A; Sayed M; Sharaf S
    Arab J Gastroenterol; 2014 Jun; 15(2):68-71. PubMed ID: 25097049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitation of alpha-fetoprotein messenger RNA for early detection of recurrent hepatocellular carcinoma: a prospective pilot study.
    Schmilovitz-Weiss H; Stemmer SM; Liberzon E; Avigad S; Sulkes J; Belinki A; Kazatsker A; Ben-Ari Z
    Cancer Detect Prev; 2006; 30(2):204-9. PubMed ID: 16638626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlation of perioperative alpha-fetoprotein expression in peripheral blood to recurrence of hepatocellular carcinoma].
    Shi M; Zhang Y; Zhong C; Lin XJ; Zhang CQ; Li JQ
    Ai Zheng; 2008 Jan; 27(1):83-7. PubMed ID: 18184471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of alpha-fetoprotein and prostate-specific antigen genes in several tissues and detection of mRNAs in normal circulating blood by reverse transcriptase-polymerase chain reaction.
    Ishikawa T; Kashiwagi H; Iwakami Y; Hirai M; Kawamura T; Aiyoshi Y; Yashiro T; Ami Y; Uchida K; Miwa M
    Jpn J Clin Oncol; 1998 Dec; 28(12):723-8. PubMed ID: 9879288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of α-fetoprotein and glypican-3 mRNAs in the peripheral blood of hepatocellular carcinoma patients by using multiple FQ-RT-PCR.
    Yan D; He Q; Chen Y; Wang L; Zhang X
    J Clin Lab Anal; 2011; 25(2):113-7. PubMed ID: 21438004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined serum hepatoma-specific alpha-fetoprotein and circulating alpha-fetoprotein-mRNA in diagnosis of hepatocellular carcinoma.
    Wu W; Yao DF; Yuan YM; Fan JW; Lu XF; Li XH; Qiu LW; Zong L; Wu XH
    Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):538-44. PubMed ID: 17085339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective evaluation of circulating hepatocytes by alpha-fetoprotein messenger RNA in patients with hepatocellular carcinoma.
    Witzigmann H; Geissler F; Benedix F; Thiery J; Uhlmann D; Tannapfel A; Wittekind C; Hauss J
    Surgery; 2002 Jan; 131(1):34-43. PubMed ID: 11812961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitation of alpha-fetoprotein and albumin messenger RNA in human hepatocellular carcinoma.
    Niwa Y; Matsumura M; Shiratori Y; Imamura M; Kato N; Shiina S; Okudaira T; Ikeda Y; Inoue T; Omata M
    Hepatology; 1996 Jun; 23(6):1384-92. PubMed ID: 8675155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematogenous spreading of hepatocellular carcinoma cells: possible participation in recurrence in the liver.
    Funaki NO; Tanaka J; Seto SI; Kasamatsu T; Kaido T; Imamura M
    Hepatology; 1997 Mar; 25(3):564-8. PubMed ID: 9049199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AFP mRNA level in enriched circulating tumor cells from hepatocellular carcinoma patient blood samples is a pivotal predictive marker for metastasis.
    Jin J; Niu X; Zou L; Li L; Li S; Han J; Zhang P; Song J; Xiao F
    Cancer Lett; 2016 Aug; 378(1):33-7. PubMed ID: 27160647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.